ALKERMES | ALKS - Ebitda

股票价格

37.48

每天变化

-0.88 -2.29%

每月一次

11.00%

每年

19.29%

Q2 预测

36.35

金融业

USD

USD 4.26B

现金及等价物

USD 351.55M

USD 73.25M

USD 1.36B

USD 599.5M

USD 1.58B

股息收益率

0

USD -48.28M

USD 80.26M

1.8K

EPS每股收益

USD -0.4

股本和储备

USD 1.75B

USD 331.33M

债务利息支出

USD 20.89M

USD 8.54M

USD 1.48B

USD 6.21B

USD -66.48M

USD 1.75B

USD -48.28M

普通股股本

USD 166.46M

39.33

USD -61.93M

USD 392.91M

销售和管理费用

USD 264.59M

USD 336.7M

贸易债权人

USD 102.36M

应收帐款人

USD 407.63M

	Ebitda	更改		日
AbbVie	USD 5.37B		1.85B	2025-12
Acadia Pharmaceuticals	USD 20.31M		15.44M	2025-12
ALKERMES	USD 80.26M		20.05M	2026-03
Amgen	USD 5.14B		775M	2025-12
Biogen	USD 649.7M		76.5M	2026-03
BioMarin Pharmaceutical	USD 146.05M		170.22M	2026-03
Bristol-Myers Squibb	USD 2.88B		1.36B	2025-12
Coherus Biosciences	USD -43.33M		4.7M	2025-09
Eli Lilly	USD 12.14B		4.26B	2025-12
Gilead Sciences	USD 3.02B		1.01B	2025-12
Heron Therapeutics	USD -3.88M		5.63M	2024-09
Ionis Pharmaceuticals	USD -200.02M		42.89M	2025-12
J&J	USD 7.19B		2.32B	2025-12
Malin Corporation	EUR -1.1M		200K	2024-12
Merck	USD 6.3B		2.09B	2025-12
Minerva Neurosciences	USD -4.36M		1.71M	2024-09
Nektar Therapeutics	USD -31.81M		70K	2023-09
Neurocrine Biosciences	USD 193.3M		25.1M	2026-03
Otsuka Holdings	JPY 156.66B		56.89B	2026-03
Pfizer	USD 5.99B		5.23B	2026-03
Regeneron Pharmaceuticals	USD 1.2B		718.4M	2025-12
Vertex Pharmaceuticals	USD 1.19B		195.3M	2026-03